Using artificial intelligence to enhance survival rates after cardiac arrest.
Artificial Intelligence to Improve Resuscitation following Out-of-Hospital Cardiac Arrest
This study is working on smarter defibrillators that use advanced technology to give personalized help to people who have a cardiac arrest outside of the hospital, aiming to improve their chances of survival during emergencies.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10983612 on NIH RePORTER |
What this research studies
This research focuses on developing advanced AI algorithms for defibrillators to improve the chances of survival for individuals experiencing out-of-hospital cardiac arrest (OHCA). By utilizing deep learning techniques, the project aims to create personalized resuscitation strategies that can adapt to the specific needs of each patient during an emergency. The research involves collaboration with experts in various fields, including emergency medicine and biostatistics, to ensure a comprehensive approach to resuscitation. Patients may benefit from more effective and tailored treatment protocols during cardiac emergencies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced out-of-hospital cardiac arrest or are at high risk for such events.
Not a fit: Patients who have not experienced cardiac arrest or have conditions that preclude resuscitation efforts may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase survival rates and improve outcomes for patients who suffer from cardiac arrest outside of a hospital setting.
How similar studies have performed: Other research has shown promising results using AI in medical emergencies, suggesting that this approach could lead to significant advancements in resuscitation techniques.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Coult, Jason — University of Washington
- Study coordinator: Coult, Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.